Evidence map›Paper›PMID 21799077›Full record

ArticleAmerican journal of respiratory and critical care medicine2011

Obesity and primary graft dysfunction after lung transplantation: the Lung Transplant Outcomes Group Obesity Study.

David J Lederer, Steven M Kawut, Nancy Wickersham, Christopher Winterbottom, Sangeeta Bhorade, Scott M Palmer, James Lee, Joshua M Diamond, Keith M Wille, Ann Weinacker and 8 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in American journal of respiratory and critical care medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed, 2 pooled it
11.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 2 syntheses or guidelines pooled it, 153 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Genetic variation in the prostaglandin E2 pathway is associated with primary graft dysfunction.American journal of respiratory and critical care medicine · 2014
    Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Development and validation of primary graft dysfunction predictive algorithm for lung transplant candidates.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2024
    Article
  18. Article
  19. Article
  20. Review

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 12 institutions in 1 country.

David J LedererDepartment of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA. davidlederer@columbia.edu
Steven M Kawut
Nancy Wickersham
Christopher Winterbottom
Sangeeta Bhorade
Scott M Palmer
James Lee
Joshua M Diamond
Keith M Wille
Ann Weinacker
Vibha N Lama
Maria Crespo
Jonathan B Orens
Joshua R Sonett
Selim M Arcasoy
Lorraine B Ware
Jason D Christie
Lung Transplant Outcomes Group
Columbia University · USCalifornia University of Pennsylvania · USVanderbilt University · USCardiovascular Institute of the South · USDuke Medical Center · USJohns Hopkins University · USStanford Medicine · USUniversity of Alabama at Birmingham · USUniversity of Chicago Medical Center · USUniversity of Michigan · USUniversity of Pennsylvania · USUniversity of Pittsburgh · US

Funding

Clinical Risk Factors for Primary Graft DysfunctionR01HL087115 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI CHRISTIE, JASON D · 2007 to 2017
$7.1M
Treatment of Pulmonary Edema in Organ DonorsR01HL088263 · NHLBI · VANDERBILT UNIVERSITY · PI WARE, LORRAINE B · 2008 to 2012
$2.3M
Midcareer Investigator Award in Patient-Oriented Research in Acute Lung InjuryK24HL103836 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WARE, LORRAINE B · 2010 to 2020
$1.6M
Implications of cardiovascular technology diffusion among Medicare beneficiariesR01HL086919 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI GROENEVELD, PETER W. · 2007 to 2009
$1.6M
Explaining Racial and Ethnic Disparities in Idiopathic Pulmonary FibrosisK23HL086714 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LEDERER, DAVID J. · 2008 to 2011
$540k
NHLBI NIH HHS K23 HL086714NHLBI NIH HHS K24 HL103836NHLBI NIH HHS R01 HL086919NHLBI NIH HHS R01 HL087115NHLBI NIH HHS R01 HL088263
6 · The paper itself

Abstract

rationaleObesity has been linked to acute lung injury and is a risk factor for early mortality after lung transplantation.

objectivesTo examine the associations of obesity and plasma adipokines with the risk of primary graft dysfunction after lung transplantation.

methodsWe performed a prospective cohort study of 512 adult lung transplant recipients with chronic obstructive pulmonary disease or interstitial lung disease enrolled in the Lung Transplant Outcomes Group Study. In a nested case-control study, we measured plasma leptin, adiponectin, and resistin before lung transplantation and 6 and 24 hours after lung transplantation in 40 cases of primary graft dysfunction and 80 control subjects. Generalized linear mixed models and logistic regression were used to estimate risk ratios and odds ratios. MEASUREMENTS AND MAIN

resultsGrade 3 primary graft dysfunction developed within 72 hours of transplantation in 29% participants. Obesity was associated with a twofold increased risk of primary graft dysfunction (adjusted risk ratio 2.1; 95% confidence interval, 1.7-2.6). The risk of primary graft dysfunction increased by 40% (confidence interval, 30–50%) for each 5 kg/m(2) increase in body mass index after accounting for center, diagnosis, cardiopulmonary bypass, and transplant procedure. Higher plasma leptin levels were associated with a greater risk of primary graft dysfunction (sex-adjusted P = 0.02). The associations of both obesity and leptin with primary graft dysfunction tended to be stronger among those who did not undergo cardiopulmonary bypass.

conclusionsObesity is an independent risk factor for primary graft dysfunction after lung transplantation.

Indexed as

AdiponectinAgedBiomarkersBody Mass IndexCase-Control StudiesFemaleHumansLeptinLinear ModelsLogistic ModelsLung Diseases, InterstitialLung TransplantationMaleMiddle AgedObesityOdds RatioAdiponectinBiomarkersLeptinResistin

Identifiers

PMID21799077
PMCPMC3208644
OpenAlexW1975989615

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.